Abstract:Ginsenoside Rh2, a promising candidate for cancer prevention and therapy, has applications in the fields of health products and pharmaceuticals. However, the current production of Rh2 through the extraction of Panaa ginseng is not sustainable and cannot meet the increasing market demand. Here, we increased the Rh2 production in Saccharomyces cerevisiae by engineering the heterologous xylose metabolic pathway. The Candida tropicalis derived xylose reductase-xylitol dehydrogenase pathway was successfully constructed in in the previously engineered protopanaxadiol (PPD)-producing strain. A PPD high-yield strain with strong xylose utilization capacity was optimized to reduce the generation of byproduct xylitol with the expression of a soluble pyridine nucleotide transhydrogenase. The new yeast chassis produced 494.0 mg/L PPD in xylose medium, which could provide sufficient precursors for Rh2. The Rh2 production strain was then constructed by integrating the glycosyltransferases UGTPg45 overexpression module and further optimized through systematic enhancement of its mevalonic acid (MVA) pathway, resulting in a Rh2 titer of 209.5 mg/L in xylose medium. In addition, we confirmed that the engineered strain also exhibited good fermentation performance in the lignocellulose hydrolysate mimic glucose-xylose mixed medium, and we further elucidated the reasons of higher Rh2 production in xylose fermentation stage through transcriptomic and metabolic analysis. Taken all strategies together, the resulting strain produced 1.47 g/L Rh2 in a 5 L bioreactor with mixed sugar medium, making it possible for a green and sustainable biotechnology to produce ginsenoside Rh2 using xylose efficiently. This is the first report on the use of xylose for high-value chemical ginsenoside Rh2 production, which will pave the way for the future industrial production of ginsenoside Rh2 from a renewable carbon source such as lignocellulose.

Synthesizing ginsenoside Rh2 in Saccharomyces cerevisiae cell factory at high-efficiency

Biosynthesis of Plant-Derived Ginsenoside Rh2 in Yeast Via Repurposing a Key Promiscuous Microbial Enzyme

Efficient Production of Ginsenoside Rh2 from Xylose by Remodeling Metabolism in Saccharomyces Cerevisiae

Construction of a Highly Efficient Synthetic Lycopene Engineered Saccharomyces Cerevisiae

Engineering yeast subcellular compartments for increased production of the lipophilic natural products ginsenosides

Promotion of Compound K Production in Saccharomyces Cerevisiae by Glycerol

Pathway elucidation of bioactive rhamnosylated ginsenosides in Panax ginseng and their de novo high-level production by engineered Saccharomyces cerevisiae

Reconstruction of engineered yeast factory for high yield production of ginsenosides Rg3 and Rd

A Novel Biosynthetic Strategy for Ginsenoside Ro: Construction of a Metabolically Engineered Saccharomyces Cerevisiae Strain Using a Newly Identified UGAT Gene from Panax Ginseng As the Key Enzyme Gene and Optimization of Fermentation Conditions

Biocatalysis for Rare Ginsenoside Rh2 Production in High Level with Co-Immobilized UDP-Glycosyltransferase Bs-YjiC Mutant and Sucrose Synthase AtSuSy

Construction of a Metabolically Engineered Saccharomyces cerevisiae Strain Using a Newly Identified UGAT Gene from Panax ginseng as the Key Enzyme Gene and Optimization of Fermentation Conditions

Cultivation optimization promotes ginsenoside and universal triterpenoid production by engineered yeast

Rerouting of NADPH synthetic pathways for increased protopanaxadiol production in Saccharomyces cerevisiae

Optimization of a Cytochrome P450 Oxidation System for Enhancing Protopanaxadiol Production in Saccharomyces Cerevisiae

Producing Aglycons of Ginsenosides in Bakers' Yeast

Oriented Efficient Biosynthesis of Rare Ginsenoside Rh2 from PPD by Compiling UGT-Yjic Mutant with Sucrose Synthase.

Production of a bioactive unnatural ginsenoside by metabolically engineered yeasts based on a new UDP-glycosyltransferase from Bacillus subtilis

Highly Efficient Production of Diverse Rare Ginsenosides Using Combinatorial Biotechnology.

Evolving the 3-O/6-O regiospecificity of a microbial glycosyltransferase for efficient production of ginsenoside Rh1 and unnatural ginsenoside

Heterologous Synthesis of Ginsenoside F2 in Saccharomyces Cerevisiae by Pathway and UDP-glycosyltransferase Engineering

Specific Glycosylation System Enables the High-Level and Sustainable Production of Glycyrrhetinic Acid 3-O-monoglucuronide and Glycyrrhizin in Engineered Saccharomyces Cerevisiae